Assessing Respiratory Motion Stability of Novel 18F-Fluorodeoxyglucose Positron Emission Tomography-Derived Morphological Features
Abstract
1. Introduction
2. Materials and Methods
2.1. Study Population
2.2. 18F-FDG PET Imaging Protocol
2.3. Image Analysis
2.3.1. Volume-of-Interest (VOI) Delineation
2.3.2. Radiomic Feature Extraction
2.3.3. Data Analysis
2.3.4. Reproducibility and Reliability Metrics
3. Results
3.1. Demographics
3.2. Reproducibility and Stability Analysis
3.3. Survival Prognostic Values
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| 18F-FDG | 18F-fluorodeoxyglucose |
| CI | Coefficient interval |
| C-index | Concordance index |
| CoV | Coefficient of variation |
| DDG | Data-driven gating |
| GLCM | Gray-level co-occurrence matrix |
| GLRLM | Gray-level run length matrix |
| HR | Hazard Ratio |
| IBSI | Image Biomarker Standardization Initiative |
| ICC | Intraclass correlation coefficient |
| IDMN | Inverse difference moment normalized |
| IDN | Inverse difference normalized |
| IRB | Institutional Review Board |
| MC | Motion Correction (respiratory-gated) |
| MTV | Metabolic Tumor Volume |
| NHOC | Normalized hotspot-to-centroid distance |
| NHOP | Normalized hotspot-to-perimeter distance |
| NMC | Non-motion correction (non-gated) |
| OS | Overall Survival |
| OSEM | Ordered-Subset Expectation Maximization |
| PET | Positron emission tomography |
| PET/CT | Positron emission tomography/computed tomography |
| SD | Standard deviation |
| SUV | Standardized uptake value |
| SUVmax | Maximum standardized uptake value |
| SUVpeak | Peak standardized uptake value |
| VOI | Volume-of-interest |
References
- Jadvar, H.; Atkins, M.B.; Bartel, T.; de Geus-Oei, L.F.; Dibble, E.H.; Halmos, B.; Subramaniam, R.M.; Ulaner, G.A.; Vaz, S.C.; Nadel, H.; et al. Summary: Appropriate use criteria for 18F-FDG PET/CT for initial staging of malignant disease. J. Nucl. Med. 2025, 66, 1034–1038. [Google Scholar] [CrossRef] [Scilit]
- Han, S.; Woo, S.; Suh, C.H.; Kim, Y.J.; Oh, J.S.; Lee, J.J. A systematic review of the prognostic value of texture analysis in 18F-FDG PET in lung cancer. Ann. Nucl. Med. 2018, 32, 602–610. [Google Scholar] [CrossRef] [Scilit]
- Liu, C.Y.; Lin, L.F.; Tsai, C.L.; Huang, T.W.; Wu, Y.C.; Liu, C.H. Baseline (1)(8)f-fdg pet/ct radiomics predict early progression and survival in small cell lung cancer. BMC Cancer 2026, 26, 222. [Google Scholar] [CrossRef] [Scilit]
- Boellaard, R. Standards for PET image acquisition and quantitative data analysis. J. Nucl. Med. 2009, 50, 11S–20S. [Google Scholar] [CrossRef] [Scilit]
- Chen, Y.H.; Kan, K.Y.; Liu, S.H.; Lin, H.H.; Lue, K.H. Impact of respiratory motion on (18) F-FDG PET radiomics stability: Clinical evaluation with a digital PET scanner. J. Appl. Clin. Med. Phys. 2023, 24, e14200. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ahn, H.K.; Lee, H.; Kim, S.G.; Hyun, S.H. Pre-treatment (18)F-FDG PET-based radiomics predict survival in resected non-small cell lung cancer. Clin. Radiol. 2019, 74, 467–473. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zuo, Y.; Liu, Q.; Li, N.; Li, P.; Zhang, J.; Song, S. Optimal (18)F-FDG PET/CT radiomics model development for predicting EGFR mutation status and prognosis in lung adenocarcinoma: A multicentric study. Front. Oncol. 2023, 13, 1173355. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jimenez Londono, G.A.; Perez-Beteta, J.; Amo-Salas, M.; Honguero-Martinez, A.F.; Perez-Garcia, V.M.; Lucas Lucas, C.; Soriano Castrejon, A.M.; Garcia Vicente, A.M. Clinicopathologic and metabolic variables from (18) F-FDG PET/CT in the prediction of recurrence pattern in stage I-III non-small cell lung cancer after curative surgery. Ann. Nucl. Med. 2025, 39, 476–505. [Google Scholar] [CrossRef] [Scilit]
- Oliver, J.A.; Budzevich, M.; Zhang, G.G.; Dilling, T.J.; Latifi, K.; Moros, E.G. Variability of image features computed from conventional and respiratory-gated PET/CT images of lung cancer. Transl. Oncol. 2015, 8, 524–534. [Google Scholar] [CrossRef] [Scilit]
- Desseroit, M.C.; Tixier, F.; Weber, W.A.; Siegel, B.A.; Cheze Le Rest, C.; Visvikis, D.; Hatt, M. Reliability of PET/CT shape and heterogeneity features in functional and morphologic components of non-small cell lung cancer tumors: A repeatability analysis in a prospective multicenter cohort. J. Nucl. Med. 2017, 58, 406–411. [Google Scholar] [CrossRef] [Scilit]
- Xu, H.; Lv, W.; Zhang, H.; Ma, J.; Zhao, P.; Lu, L. Evaluation and optimization of radiomics features stability to respiratory motion in (18) f-fdg 3d pet imaging. Med. Phys. 2021, 48, 5165–5178. [Google Scholar] [CrossRef] [Scilit]
- Felicetti, F.; Lamonaca, F.; Carnì, D.L.; Costanzo, S. Image quality standardization in radiomics: A systematic review of artifacts, variability, and feature stability. Sensors 2026, 26, 1039. [Google Scholar] [CrossRef] [Scilit]
- Hovhannisyan-Baghdasarian, N.; Luporsi, M.; Captier, N.; Nioche, C.; Cuplov, V.; Woff, E.; Hegarat, N.; Livartowski, A.; Girard, N.; Buvat, I.; et al. Promising candidate prognostic biomarkers in [18F] FDG PET images: Evaluation in independent cohorts of non-small cell lung cancer patients. J. Nucl. Med. 2024, 65, 635–642. [Google Scholar] [CrossRef] [Scilit]
- Hong, S.P.; Lee, S.M.; Yoo, I.D.; Jo, I.Y.; Won, Y.K.; Kim, M.S.; Choi, H.J.; Lee, J.W.; Jang, S.J. Prognostic significance of normalized distance from maximum standardized uptake value to tumor centroid on [18F] FDG PET/ct in head and neck squamous cell carcinoma. Rev. Esp. Med. Nucl. Imagen Mol. (Engl. Ed.) 2025, 44, 500103. [Google Scholar] [CrossRef] [Scilit]
- Mayerhoefer, M.E.; Materka, A.; Langs, G.; Häggström, I.; Szczypiński, P.; Gibbs, P.; Cook, G. Introduction to Radiomics. J. Nucl. Med. 2020, 61, 488–495. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Nioche, C.; Orlhac, F.; Boughdad, S.; Reuze, S.; Goya-Outi, J.; Robert, C.; Pellot-Barakat, C.; Soussan, M.; Frouin, F.; Buvat, I. Lifex: A freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res. 2018, 78, 4786–4789. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hatt, M.; Krizsan, A.K.; Rahmim, A.; Bradshaw, T.J.; Costa, P.F.; Forgacs, A.; Seifert, R.; Zwanenburg, A.; El Naqa, I.; Kinahan, P.E.; et al. Joint EANM/SNMMI guidelines on radiomics in nuclear medicine: Jointly supported by the EANM Physics Committee and Snmmi Physics, Instrumentation, and Data Sciences Council. Eur. J. Nucl. Med. Mol. Imaging 2023, 50, 352–375. [Google Scholar] [CrossRef] [Scilit]
- Zwanenburg, A.; Vallieres, M.; Abdalah, M.A.; Aerts, H.; Andrearczyk, V.; Apte, A.; Ashrafinia, S.; Bakas, S.; Beukinga, R.J.; Boellaard, R.; et al. The image biomarker standardization initiative: Standardized quantitative radiomics for high-throughput image-based phenotyping. Radiology 2020, 295, 328–338. [Google Scholar] [CrossRef] [Scilit]
- Wahl, R.L.; Jacene, H.; Kasamon, Y.; Lodge, M.A. From recist to percist: Evolving considerations for pet response criteria in solid tumors. J. Nucl. Med. 2009, 50, 122S–150S. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Soret, M.; Bacharach, S.L.; Buvat, I. Partial-volume effect in PET tumor imaging. J. Nucl. Med. 2007, 48, 932–945. [Google Scholar] [CrossRef] [Scilit]
- Marquis, H.; Willowson, K.P.; Bailey, D.L. Partial volume effect in SPECT & PET imaging and impact on radionuclide dosimetry estimates. Asia Ocean. J. Nucl. Med. Biol. 2023, 11, 44–54. [Google Scholar]
- Cox, D.R. Regression models and life-tables. J. R. Stat. Soc. Ser. B (Methodol.) 1972, 34, 187–220. [Google Scholar] [CrossRef] [Scilit]
- Harrell, F.E., Jr.; Lee, K.L.; Mark, D.B. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat. Med. 1996, 15, 361–387. [Google Scholar] [CrossRef] [Scilit]
- van der Vos, C.S.; Koopman, D.; Rijnsdorp, S.; Arends, A.J.; Boellaard, R.; van Dalen, J.A.; Lubberink, M.; Willemsen, A.T.M.; Visser, E.P. Quantification, improvement, and harmonization of small lesion detection with state-of-the-art PET. Eur. J. Nucl. Med. Mol. Imaging 2017, 44, 4–16. [Google Scholar] [CrossRef] [Scilit]
- Hosseini, S.A.; Shiri, I.; Hajianfar, G.; Bahadorzadeh, B.; Ghafarian, P.; Zaidi, H.; Ay, M.R. Synergistic impact of motion and acquisition/reconstruction parameters on [18 F] FDG PET radiomic features in non-small cell lung cancer: Phantom and clinical studies. Med. Phys. 2022, 49, 3783–3796. [Google Scholar] [CrossRef] [Scilit]
- Mahmoud, H.A.; Oteify, W.; Elkhayat, H.; Zaher, A.M.; Mohran, T.Z.; Mekkawy, N. Volumetric parameters of the primary tumor and whole-body tumor burden derived from baseline [18F] FDG PET/ct can predict overall survival in non-small cell lung cancer patients: Initial results from a single institution. Eur. J. Hybrid. Imaging 2022, 6, 37. [Google Scholar] [CrossRef] [Scilit]
- Alsyed, E.; Smith, R.; Bartley, L.; Marshall, C.; Spezi, E. A heterogeneous phantom study for investigating the stability of PET images radiomic features with varying reconstruction settings. Front. Nucl. Med. 2023, 3, 1078536. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Manafi-Farid, R.; Askari, E.; Shiri, I.; Pirich, C.; Asadi, M.; Khateri, M.; Zaidi, H.; Beheshti, M. [(18)f]fdg-pet/ct radiomics and artificial intelligence in lung cancer: Technical aspects and potential clinical applications. Semin. Nucl. Med. 2022, 52, 759–780. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Hirata, K.; Kamagata, K.; Ueda, D.; Yanagawa, M.; Kawamura, M.; Nakaura, T.; Ito, R.; Tatsugami, F.; Matsui, Y.; Yamada, A.; et al. From fdg and beyond: The evolving potential of nuclear medicine. Ann. Nucl. Med. 2023, 37, 583–595. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chen, Y.H.; Lue, K.H.; Chu, S.C.; Chang, B.S.; Lin, C.B. The combined tumor-nodal glycolytic entropy improves survival stratification in nonsmall cell lung cancer with locoregional disease. Nucl. Med. Commun. 2023, 44, 100–107. [Google Scholar] [CrossRef] [Scilit]
- Chen, Y.H.; Yong, L.M.; Wu, Y.F.; Liu, S.H.; Lue, K.H. Influence of feature aggregation and selection methods on fluorine-18 fluorodeoxyglucose PET radiomics for survival prediction in patients with lymphoma. Nucl. Med. Commun. 2026, 47, 462–469. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lue, K.H.; Wang, Y.H.; Chen, Y.H.; Chu, S.C.; Lin, C.B.; Liu, S.H. The prognostic value of 18F-FDG PET-derived whole-body feature in patients with lung adenocarcinoma treated with EGFR-targeted therapy. Ann. Nucl. Med. 2026, 40, 121–135. [Google Scholar] [CrossRef] [Scilit]
- van Velden, F.H.; Kramer, G.M.; Frings, V.; Nissen, I.A.; Mulder, E.R.; de Langen, A.J.; Hoekstra, O.S.; Smit, E.F.; Boellaard, R. Repeatability of radiomic features in non-small-cell lung cancer [(18)f]fdg-pet/ct studies: Impact of reconstruction and delineation. Mol. Imaging Biol. 2016, 18, 788–795. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Traverso, A.; Wee, L.; Dekker, A.; Gillies, R. Repeatability and reproducibility of radiomic features: A systematic review. Int. J. Radiat. Oncol. Biol. Phys. 2018, 102, 1143–1158. [Google Scholar] [CrossRef] [Scilit]
- Bray, F.; Laversanne, M.; Sung, H.; Ferlay, J.; Siegel, R.L.; Soerjomataram, I.; Jemal, A. Global cancer statistics 2022: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2024, 74, 229–263. [Google Scholar] [CrossRef] [Scilit]
- Thai, A.A.; Solomon, B.J.; Sequist, L.V.; Gainor, J.F.; Heist, R.S. Lung cancer. Lancet 2021, 398, 535–554. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tang, F.H.; Wong, H.Y.T.; Tsang, P.S.W.; Yau, M.; Tam, S.Y.; Law, L.; Yau, K.; Wong, J.; Farah, F.H.M.; Wong, J. Recent advancements in lung cancer research: A narrative review. Transl. Lung Cancer Res. 2025, 14, 975–990. [Google Scholar] [CrossRef] [Scilit]
- Smolarz, B.; Lukasiewicz, H.; Samulak, D.; Piekarska, E.; Kolacinski, R.; Romanowicz, H. Lung cancer-epidemiology, pathogenesis, treatment and molecular aspect (review of literature). Int. J. Mol. Sci. 2025, 26, 2049. [Google Scholar] [CrossRef] [Scilit]

| Characteristic | Value (%) |
|---|---|
| Sex, n | 138 |
| Male | 78 (56.5%) |
| Female | 60 (43.5%) |
| Age | 61.5 ± 11.5 |
| Lesion | 203 |
| MTV < 3 mL | 60 (29.6%) |
| MTV ≥ 3 mL | 143 (70.4%) |
| Cancer | |
| Lung cancer | 74 (53.6%) |
| Small cell carcinoma | 3 (2.2%) |
| Adenocarcinoma | 61 (44.2%) |
| Squamous cell carcinoma | 9 (6.5%) |
| Poorly differentiated carcinoma | 1 (0.7%) |
| Others | 64 (46.4%) |
| Head and neck cancer | 16 (11.6%) |
| Colorectal cancer | 15 (10.9%) |
| Esophageal cancer | 15 (10.9%) |
| Breast cancer | 6 (4.3%) |
| Lymphoma | 4 (3.0%) |
| Gynecologic cancer | 3 (2.2%) |
| Genitourinary cancer | 2 (1.4%) |
| Pancreatic cancer | 2 (1.4%) |
| Liver cancer | 1 (0.7%) |
| Features | OS | |||
|---|---|---|---|---|
| MC | NMC | |||
| HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
| SUVmax | 1.081 (1.018–1.147) | 0.010 | 1.090 (1.023–1.161) | 0.007 |
| NHOCmax | 2.841 (1.042–7.747) | 0.041 | 3.644 (1.263–10.509) | 0.017 |
| NHOCpeak a | 4.813 (1.337–17.331) | 0.016 | 4.971 (1.496–16.518) | 0.009 |
| NHOPmax | 0.152 (0.01–2.329) | 0.176 | 0.119 (0.01–1.432) | 0.094 |
| NHOPpeak a | 0.020 (6.374 × 10−4–0.599) | 0.024 | 0.042 (0.002–0.988) | 0.049 |
| Sphericity | 0.017 (0.002–0.177) | <0.001 | 0.011 (8.132 × 10−4–0.141) | <0.001 |
| Entropy | 1.655 (1.148–2.386) | 0.007 | 1.849 (1.236–2.765) | 0.003 |
| Joint Entropy | 1.371 (1.097–1.713) | 0.006 | 1.405 (1.121–1.762) | 0.003 |
| Sum Entropy | 1.371 (1.097–1.713) | 0.006 | 1.405 (1.121–1.762) | 0.003 |
| Run Entropy | 1.803 (1.196–2.718) | 0.005 | 2.119 (1.335–3.364) | 0.001 |
| IDN b | 1.011 (1.001–1.022) | 0.028 | 1.013 (1.002–1.024) | 0.019 |
| IDMN b | 1.019 (1.002–1.037) | 0.029 | 1.023 (1.004–1.042) | 0.016 |
| Features | OS | |||
|---|---|---|---|---|
| MC | NMC | |||
| HR (95% CI) | p-Value | HR (95% CI) | p-Value | |
| SUVmax | 1.046 (1.011–1.082) | 0.009 | 1.049 (1.012–1.087) | 0.009 |
| NHOCmax | 2.380 (1.035–5.472) | 0.041 | 1.855 (0.628–5.484) | 0.264 |
| NHOCpeak a | 3.764 (0.970–14.611) | 0.055 | 5.408 (1.336–21.897) | 0.018 |
| NHOPmax | 0.475 (0.032–7.060) | 0.589 | 0.530 (0.031–9.150) | 0.663 |
| NHOPpeak a | 0.052 (0.002–1.495) | 0.085 | 0.319 (0.010–9.895) | 0.515 |
| Sphericity | 0.010 (6.744 × 10−4–0.155) | <0.001 | 0.004 (2.200 × 10−4–0.092) | <0.001 |
| Entropy | 1.654 (1.095–2.497) | 0.017 | 1.764 (1.176–2.645) | 0.006 |
| Joint Entropy | 1.371 (1.053–1.648) | 0.016 | 1.354 (1.086–1.689) | 0.007 |
| Sum Entropy | 1.371 (1.053–1.648) | 0.016 | 1.354 (1.086–1.689) | 0.007 |
| Run Entropy | 1.935 (1.187–3.154) | 0.008 | 2.070 (1.273–3.366) | 0.003 |
| IDN b | 1.016 (1.003–1.030) | 0.019 | 1.014 (1.000–1.028) | 0.043 |
| IDMN b | 1.035 (1.004–1.067) | 0.027 | 1.029 (0.998–1.061) | 0.066 |
| Original | ||||
| Features | c-Index for Non-Corrected PET | c-Index for Respiratory Motion Corrected PET | p-Value | 95% CI for c-Index Difference |
| SUVmax | 0.642 | 0.643 | 0.910 | −0.020–0.020 |
| NHOCmax | 0.613 | 0.595 | 0.576 | −0.019–0.026 |
| NHOCpeak a | 0.600 | 0.588 | 0.570 | −0.045–0.082 |
| NHOPmax | 0.577 | 0.593 | 0.740 | −0.039–0.064 |
| NHOPpeak b | 0.607 | 0.622 | 0.738 | −0.078–0.110 |
| Sphericity | 0.621 | 0.624 | 0.719 | −0.083–0.116 |
| Entropy | 0.640 | 0.630 | 0.455 | −0.023–0.040 |
| Joint entropy | 0.642 | 0.632 | 0.305 | −0.015–0.035 |
| Sum entropy | 0.642 | 0.632 | 0.305 | −0.015–0.035 |
| Run entropy | 0.655 | 0.635 | 0.145 | −0.045–0.053 |
| IDN | 0.607 | 0.602 | 0.822 | −0.044–0.069 |
| IDMN | 0.614 | 0.601 | 0.591 | −0.009–0.051 |
| Spatially Re-Sampled Images | ||||
| Features | c-Index for Respiratory Motion-Corrected PET | c-Index for Non-Corrected PET | p-Value | 95% CI for c-Index Difference |
| SUVmax | 0.653 | 0.641 | 0.132 | −0.034–0.006 |
| NHOCmax | 0.553 | 0.569 | 0.605 | −0.018–0.060 |
| NHOCpeak c | 0.602 | 0.576 | 0.218 | −0.077–0.049 |
| NHOPmax | 0.530 | 0.541 | 0.797 | −0.020–0.076 |
| NHOPpeak d | 0.536 | 0.611 | 0.077 | −0.085–0.098 |
| Sphericity | 0.604 | 0.623 | 0.272 | −0.007–0.163 |
| Entropy | 0.631 | 0.617 | 0.156 | −0.011–0.038 |
| Joint entropy | 0.623 | 0.616 | 0.550 | −0.023–0.033 |
| Sum entropy | 0.623 | 0.616 | 0.551 | −0.023–0.033 |
| Run entropy | 0.645 | 0.623 | 0.071 | −0.073–0.013 |
| IDN | 0.606 | 0.634 | 0.135 | −0.085–0.016 |
| IDMN | 0.603 | 0.636 | 0.140 | −0.006–0.049 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Tan, S.I.; Lue, K.-H.; Chen, Y.-H.; Chu, S.-C.; Lin, C.-B.; Liu, S.-H. Assessing Respiratory Motion Stability of Novel 18F-Fluorodeoxyglucose Positron Emission Tomography-Derived Morphological Features. Diagnostics 2026, 16, 994. https://doi.org/10.3390/diagnostics16070994
Tan SI, Lue K-H, Chen Y-H, Chu S-C, Lin C-B, Liu S-H. Assessing Respiratory Motion Stability of Novel 18F-Fluorodeoxyglucose Positron Emission Tomography-Derived Morphological Features. Diagnostics. 2026; 16(7):994. https://doi.org/10.3390/diagnostics16070994
Chicago/Turabian StyleTan, Sze Ian, Kun-Han Lue, Yu-Hung Chen, Sung-Chao Chu, Chih-Bin Lin, and Shu-Hsin Liu. 2026. "Assessing Respiratory Motion Stability of Novel 18F-Fluorodeoxyglucose Positron Emission Tomography-Derived Morphological Features" Diagnostics 16, no. 7: 994. https://doi.org/10.3390/diagnostics16070994
APA StyleTan, S. I., Lue, K.-H., Chen, Y.-H., Chu, S.-C., Lin, C.-B., & Liu, S.-H. (2026). Assessing Respiratory Motion Stability of Novel 18F-Fluorodeoxyglucose Positron Emission Tomography-Derived Morphological Features. Diagnostics, 16(7), 994. https://doi.org/10.3390/diagnostics16070994

